1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy
1.2.3 Contract Outsourcing
1.3 Market by Application
1.3.1 Global Pharmacovigilance Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharma and Biotech Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Business Process Outsourcing (BPO) Firms
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Pharmacovigilance Market Perspective (2017-2028)
2.2 Pharmacovigilance Growth Trends by Region
2.2.1 Pharmacovigilance Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmacovigilance Historic Market Size by Region (2017-2022)
2.2.3 Pharmacovigilance Forecasted Market Size by Region (2023-2028)
2.3 Pharmacovigilance Market Dynamics
2.3.1 Pharmacovigilance Industry Trends
2.3.2 Pharmacovigilance Market Drivers
2.3.3 Pharmacovigilance Market Challenges
2.3.4 Pharmacovigilance Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance Players by Revenue
3.1.1 Global Top Pharmacovigilance Players by Revenue (2017-2022)
3.1.2 Global Pharmacovigilance Revenue Market Share by Players (2017-2022)
3.2 Global Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance Revenue
3.4 Global Pharmacovigilance Market Concentration Ratio
3.4.1 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Revenue in 2021
3.5 Pharmacovigilance Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance Product Solution and Service
3.7 Date of Enter into Pharmacovigilance Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Pharmacovigilance Breakdown Data by Type
4.1 Global Pharmacovigilance Historic Market Size by Type (2017-2022)
4.2 Global Pharmacovigilance Forecasted Market Size by Type (2023-2028) 5 Pharmacovigilance Breakdown Data by Application
5.1 Global Pharmacovigilance Historic Market Size by Application (2017-2022)
5.2 Global Pharmacovigilance Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Pharmacovigilance Market Size (2017-2028)
6.2 North America Pharmacovigilance Market Size by Type
6.2.1 North America Pharmacovigilance Market Size by Type (2017-2022)
6.2.2 North America Pharmacovigilance Market Size by Type (2023-2028)
6.2.3 North America Pharmacovigilance Market Share by Type (2017-2028)
6.3 North America Pharmacovigilance Market Size by Application
6.3.1 North America Pharmacovigilance Market Size by Application (2017-2022)
6.3.2 North America Pharmacovigilance Market Size by Application (2023-2028)
6.3.3 North America Pharmacovigilance Market Share by Application (2017-2028)
6.4 North America Pharmacovigilance Market Size by Country
6.4.1 North America Pharmacovigilance Market Size by Country (2017-2022)
6.4.2 North America Pharmacovigilance Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Pharmacovigilance Market Size (2017-2028)
7.2 Europe Pharmacovigilance Market Size by Type
7.2.1 Europe Pharmacovigilance Market Size by Type (2017-2022)
7.2.2 Europe Pharmacovigilance Market Size by Type (2023-2028)
7.2.3 Europe Pharmacovigilance Market Share by Type (2017-2028)
7.3 Europe Pharmacovigilance Market Size by Application
7.3.1 Europe Pharmacovigilance Market Size by Application (2017-2022)
7.3.2 Europe Pharmacovigilance Market Size by Application (2023-2028)
7.3.3 Europe Pharmacovigilance Market Share by Application (2017-2028)
7.4 Europe Pharmacovigilance Market Size by Country
7.4.1 Europe Pharmacovigilance Market Size by Country (2017-2022)
7.4.2 Europe Pharmacovigilance Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance Market Size (2017-2028)
8.2 Asia-Pacific Pharmacovigilance Market Size by Type
8.2.1 Asia-Pacific Pharmacovigilance Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pharmacovigilance Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pharmacovigilance Market Share by Type (2017-2028)
8.3 Asia-Pacific Pharmacovigilance Market Size by Application
8.3.1 Asia-Pacific Pharmacovigilance Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pharmacovigilance Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pharmacovigilance Market Share by Application (2017-2028)
8.4 Asia-Pacific Pharmacovigilance Market Size by Region
8.4.1 Asia-Pacific Pharmacovigilance Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pharmacovigilance Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Pharmacovigilance Market Size (2017-2028)
9.2 Latin America Pharmacovigilance Market Size by Type
9.2.1 Latin America Pharmacovigilance Market Size by Type (2017-2022)
9.2.2 Latin America Pharmacovigilance Market Size by Type (2023-2028)
9.2.3 Latin America Pharmacovigilance Market Share by Type (2017-2028)
9.3 Latin America Pharmacovigilance Market Size by Application
9.3.1 Latin America Pharmacovigilance Market Size by Application (2017-2022)
9.3.2 Latin America Pharmacovigilance Market Size by Application (2023-2028)
9.3.3 Latin America Pharmacovigilance Market Share by Application (2017-2028)
9.4 Latin America Pharmacovigilance Market Size by Country
9.4.1 Latin America Pharmacovigilance Market Size by Country (2017-2022)
9.4.2 Latin America Pharmacovigilance Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance Market Size (2017-2028)
10.2 Middle East & Africa Pharmacovigilance Market Size by Type
10.2.1 Middle East & Africa Pharmacovigilance Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pharmacovigilance Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pharmacovigilance Market Share by Type (2017-2028)
10.3 Middle East & Africa Pharmacovigilance Market Size by Application
10.3.1 Middle East & Africa Pharmacovigilance Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pharmacovigilance Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pharmacovigilance Market Share by Application (2017-2028)
10.4 Middle East & Africa Pharmacovigilance Market Size by Country
10.4.1 Middle East & Africa Pharmacovigilance Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pharmacovigilance Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Pharmacovigilance Introduction
11.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2017-2022)
11.1.5 Eli Lilly and Company Recent Developments
11.2 ICON
11.2.1 ICON Company Details
11.2.2 ICON Business Overview
11.2.3 ICON Pharmacovigilance Introduction
11.2.4 ICON Revenue in Pharmacovigilance Business (2017-2022)
11.2.5 ICON Recent Developments
11.3 Elsevier
11.3.1 Elsevier Company Details
11.3.2 Elsevier Business Overview
11.3.3 Elsevier Pharmacovigilance Introduction
11.3.4 Elsevier Revenue in Pharmacovigilance Business (2017-2022)
11.3.5 Elsevier Recent Developments
11.4 Chiltern
11.4.1 Chiltern Company Details
11.4.2 Chiltern Business Overview
11.4.3 Chiltern Pharmacovigilance Introduction
11.4.4 Chiltern Revenue in Pharmacovigilance Business (2017-2022)
11.4.5 Chiltern Recent Developments
11.5 Atlantic Research Group
11.5.1 Atlantic Research Group Company Details
11.5.2 Atlantic Research Group Business Overview
11.5.3 Atlantic Research Group Pharmacovigilance Introduction
11.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2017-2022)
11.5.5 Atlantic Research Group Recent Developments
11.6 Mapi Group
11.6.1 Mapi Group Company Details
11.6.2 Mapi Group Business Overview
11.6.3 Mapi Group Pharmacovigilance Introduction
11.6.4 Mapi Group Revenue in Pharmacovigilance Business (2017-2022)
11.6.5 Mapi Group Recent Developments
11.7 Accenture
11.7.1 Accenture Company Details
11.7.2 Accenture Business Overview
11.7.3 Accenture Pharmacovigilance Introduction
11.7.4 Accenture Revenue in Pharmacovigilance Business (2017-2022)
11.7.5 Accenture Recent Developments
11.8 Clinquest Group
11.8.1 Clinquest Group Company Details
11.8.2 Clinquest Group Business Overview
11.8.3 Clinquest Group Pharmacovigilance Introduction
11.8.4 Clinquest Group Revenue in Pharmacovigilance Business (2017-2022)
11.8.5 Clinquest Group Recent Developments
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Pharmacovigilance Introduction
11.9.4 GSK Revenue in Pharmacovigilance Business (2017-2022)
11.9.5 GSK Recent Developments
11.10 PRA Health Sciences
11.10.1 PRA Health Sciences Company Details
11.10.2 PRA Health Sciences Business Overview
11.10.3 PRA Health Sciences Pharmacovigilance Introduction
11.10.4 PRA Health Sciences Revenue in Pharmacovigilance Business (2017-2022)
11.10.5 PRA Health Sciences Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
